ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.065,54
-0,35%
S&P 500
5.300,61
1,03%
US Dollar vs BRL
5,1411
0,23%
Bitcoin
65.693,01
6,75%
Brent Oil
82,605
0,07%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Cipher Pharmaceuticals Inc (CPH)

  7. Cipher Pharmaceuticals Inc (CPH) Notícias

CPH

Cipher Pharmaceuticals (CPH)

Cipher Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:CPH
DataHoraFonteTítuloCódigoCompanhia
09/05/202418:00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter 2024 ResultsTSX:CPHCipher Pharmaceuticals Inc
03/05/202408:05PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
14/03/202418:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsTSX:CPHCipher Pharmaceuticals Inc
08/03/202409:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
29/01/202414:56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202414:56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202409:15PR Newswire (Canada)Cipher Pharmaceuticals Announces the Commencement of OTCQX TradingTSX:CPHCipher Pharmaceuticals Inc
24/11/202319:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Change of AuditorTSX:CPHCipher Pharmaceuticals Inc
15/11/202319:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
09/11/202319:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023TSX:CPHCipher Pharmaceuticals Inc
27/10/202308:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
12/10/202310:57PR Newswire (Canada)Cipher Pharmaceuticals Announces Final Results of Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
03/10/202308:00PR Newswire (Canada)Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
05/09/202308:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsTSX:CPHCipher Pharmaceuticals Inc
10/08/202318:00PR Newswire (Canada)Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoTSX:CPHCipher Pharmaceuticals Inc
28/07/202308:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
05/07/202308:00PR Newswire (Canada)Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionTSX:CPHCipher Pharmaceuticals Inc
21/06/202313:53PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersTSX:CPHCipher Pharmaceuticals Inc
11/05/202318:00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityTSX:CPHCipher Pharmaceuticals Inc
04/05/202318:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
16/03/202318:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
10/03/202319:30PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
01/03/202309:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityTSX:CPHCipher Pharmaceuticals Inc
10/11/202220:30PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareTSX:CPHCipher Pharmaceuticals Inc
26/10/202208:00PR Newswire (Canada)CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALLTSX:CPHCipher Pharmaceuticals Inc
11/08/202218:45PR Newswire (Canada)Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOTSX:CPHCipher Pharmaceuticals Inc
11/08/202218:01PR Newswire (Canada)Cipher Pharmaceuticals Reports Second Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
05/08/202208:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
22/06/202218:01PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullTSX:CPHCipher Pharmaceuticals Inc
12/05/202218:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:TSX:CPH

Seu Histórico Recente

AQEU
BOC
Bang & Olufsen AS
BIT
F29102
Vontobel Financial Produ...
HITB
HSRBTC
Hcash
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados